Antimicrobial Agents Practice Questions

Q: What is the mechanism of action of aminoglycosides?

Inhibition of protein synthesis. **Explanation:** Aminoglycosides (e.g., Gentamicin, Amikacin, Streptomycin) are potent bactericidal antibiotics that act by **inhibiting protein synthesis**. They bind irreversibly to the **30S ribosomal subunit**, leading to three primary effects: 1. Interference with the initiation complex of peptide formation. 2. Induction of mRNA misreading, resulting in the synthesis of non-functional or toxic proteins. 3. Breakup of polysomes into non-functional monosomes. **Analysis of Options:** * **Option A (Correct):** Aminoglycosides specifically target the 30S subunit to halt translation. * **Option B (Incorrect):** This is the mechanism of Polymyxins (Daptomycin/Colistin) and certain antifungals (Amphotericin B), which disrupt the integrity of the bacterial or fungal membrane. * **Option C (Incorrect):** Protein coagulation is a non-specific mechanism characteristic of antiseptics and disinfectants (like phenols or alcohols), not selective antibiotics. * **Option D (Incorrect):** This describes the mechanism of Beta-lactams (Penicillins, Cephalosporins) and Glycopeptides (Vancomycin), which target peptidoglycan synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Bactericidal Exception:** Unlike most protein synthesis inhibitors (which are bacteriostatic), aminoglycosides are **bactericidal**. * **Oxygen Dependency:** Their transport into bacteria is oxygen-dependent; therefore, they are **ineffective against anaerobes**. * **Post-Antibiotic Effect (PAE):** They exhibit a significant PAE, allowing for once-daily dosing despite a short half-life. * **Toxicity:** Monitor for **Ototoxicity** (vestibular/cochlear damage) and **Nephrotoxicity** (Acute Tubular Necrosis). * **Synergy:** They are often combined with cell wall inhibitors (like Penicillins) to facilitate entry into the cell, especially in treating Enterococcal endocarditis.

Q: All of the following are antifungal drugs that inhibit ergosterol biosynthesis EXCEPT?

Amphotericin B. ### Explanation The cell membrane of fungi contains **ergosterol**, a vital sterol that maintains membrane integrity. Antifungal agents target this pathway in two distinct ways: by inhibiting its **synthesis** or by binding to the **existing sterol** to cause membrane damage. **1. Why Amphotericin B is the correct answer:** Amphotericin B belongs to the **Polyene** class. Unlike Azoles, it does **not** inhibit the biosynthesis of ergosterol. Instead, it binds directly to the pre-formed ergosterol molecules already present in the fungal cell membrane [3]. This binding creates transmembrane pores (ion channels), leading to the leakage of intracellular contents (like $K^+$) and subsequent cell death [2]. **2. Why the other options are incorrect:** * **Ketoconazole & Fluconazole:** These are **Azoles**. They work by inhibiting the enzyme **14-$\alpha$-demethylase** (a cytochrome P450 enzyme) [1]. This enzyme is responsible for converting lanosterol into ergosterol. By blocking this step, they inhibit the **biosynthesis** of ergosterol, leading to the accumulation of toxic precursor sterols and membrane dysfunction [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Resistance to Amphotericin B occurs via a decrease in the ergosterol content of the fungal membrane. * **Side Effects of Amphotericin B:** Known for "infusion-related reactions" (fever, chills) and **nephrotoxicity** (causes distal renal tubular acidosis and hypokalemia) [3], [5]. Liposomal formulations are used to reduce toxicity [5]. * **Terbinafine:** Another inhibitor of ergosterol biosynthesis, but it acts earlier in the pathway by inhibiting **Squalene epoxidase**. * **Echinocandins (e.g., Caspofungin):** These do NOT target ergosterol; they inhibit the synthesis of **$\beta$-(1,3)-D-glucan**, a component of the fungal **cell wall** [4].

Q: Which of the following is the drug of choice for Campylobacter jejuni infection?

Erythromycin. **Explanation:** *Campylobacter jejuni* is one of the most common causes of bacterial gastroenteritis worldwide, typically presenting as inflammatory diarrhea (bloody stools), fever, and abdominal cramps. **1. Why Erythromycin is the Correct Answer:** Macrolides are the mainstay of treatment for *Campylobacter* enteritis. While many modern guidelines mention Azithromycin due to its convenient once-daily dosing, **Erythromycin** remains the classic "Drug of Choice" (DOC) cited in standard pharmacology textbooks (like K.D. Tripathi) and frequently tested in NEET-PG. It effectively shortens the duration of pathogen excretion and reduces the severity of symptoms if administered early. **2. Why Other Options are Incorrect:** * **Azithromycin (Option A):** While clinically effective and often preferred in practice due to better GI tolerance, Erythromycin is traditionally established as the gold standard in academic examinations for this specific organism. * **Metronidazole (Option B):** This is the DOC for anaerobic infections and protozoal diseases like Amoebiasis or Giardiasis. It has no activity against *Campylobacter*. * **Ampicillin (Option C):** *Campylobacter* species show high rates of resistance to penicillins; therefore, they are not used for empirical or definitive treatment. **3. High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** *C. jejuni* is a Gram-negative, comma or S-shaped organism ("seagull wing" appearance) that is microaerophilic and grows best at 42°C (Skirrow’s medium). * **Complication:** It is the most common antecedent infection associated with **Guillain-Barré Syndrome (GBS)** due to molecular mimicry. * **Resistance Trend:** Fluoroquinolones (like Ciprofloxacin) were previously used but are now avoided due to rapidly rising resistance. * **Treatment Note:** Most cases are self-limiting and require only oral rehydration; antibiotics are reserved for severe or prolonged cases.

Q: What is the standard oral dose of oseltamivir for treatment?

75 mg twice daily for 5 days orally. **Explanation:** **Oseltamivir** is a neuraminidase inhibitor used for the treatment and prophylaxis of Influenza A and B. It works by preventing the release of new viral particles from infected host cells. **1. Why Option A is Correct:** The standard therapeutic dose for adults and adolescents (weighing >40 kg) is **75 mg twice daily (BID) for 5 days**. For the drug to be most effective, it must be initiated within **48 hours** of the onset of symptoms. It is administered **orally** as a prodrug (oseltamivir phosphate), which is rapidly converted by hepatic esterases into its active form, oseltamivir carboxylate. **2. Why Other Options are Incorrect:** * **Options B & D:** Oseltamivir is specifically an **oral** medication. If intravenous neuraminidase inhibition is required (e.g., in critically ill patients unable to tolerate oral meds), **Peramivir** is the drug of choice. * **Option C:** 200 mg is not a standard dose. Higher doses (e.g., 150 mg BID) have been studied for severe infections (H5N1) or immunocompromised patients, but 75 mg BID remains the gold standard for seasonal influenza. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis Dose:** 75 mg **once daily** for 7–10 days (post-exposure) or up to 6 weeks (during community outbreaks). * **Mechanism:** Competitive inhibition of **Neuraminidase**, preventing viral shedding. * **Pregnancy:** Oseltamivir is the preferred antiviral for pregnant women with influenza. * **Side Effects:** Most common are GI upset (nausea/vomiting); rare but serious neuropsychiatric events (confusion, self-injury) have been reported in children. * **Zanamivir:** An alternative neuraminidase inhibitor administered via **inhalation** (contraindicated in asthma/COPD due to risk of bronchospasm).

Q: What is the most important side effect of Amphotericin B?

Nephrotoxicity. **Explanation:** **Amphotericin B** is a potent polyene antifungal used for systemic fungal infections. While it has several adverse effects, **Nephrotoxicity** is the most significant and dose-limiting side effect. **1. Why Nephrotoxicity is the Correct Answer:** Amphotericin B works by binding to ergosterol in fungal cell membranes to create pores. However, it also has a partial affinity for **cholesterol** in human renal tubular cells. This leads to: * **Direct Toxicity:** Damage to the renal tubular epithelium, causing electrolyte wasting (Type 1 RTA). * **Indirect Toxicity:** Vasoconstriction of the afferent arterioles, leading to decreased Renal Blood Flow (RBF) and Glomerular Filtration Rate (GFR). This "azotemia" occurs in nearly 80% of patients treated with the conventional deoxycholate form. **2. Analysis of Incorrect Options:** * **A. Fever and Chills:** These are common **infusion-related reactions** (the "shake and bake" phenomenon). While frequent, they are transient and manageable with premedication (NSAIDs/steroids), unlike the cumulative damage of nephrotoxicity. * **C. Hyperkalemia:** This is incorrect because Amphotericin B typically causes **Hypokalemia** and **Hypomagnesemia** due to increased distal tubular permeability and wasting. * **D. Anemia:** It causes a normocytic normochromic anemia due to decreased erythropoietin production by the damaged kidneys, but it is secondary to the renal impact. **High-Yield Clinical Pearls for NEET-PG:** * **Liposomal Amphotericin B:** Developed to reduce nephrotoxicity by targeting the drug specifically to fungal cells and avoiding the kidneys. * **Saline Loading:** Administering 1 liter of normal saline before the infusion is the standard clinical practice to minimize nephrotoxicity. * **Drug of Choice:** Despite its toxicity, it remains the gold standard for **Mucormycosis** and severe **Visceral Leishmaniasis**.

Q: According to the recent classification of antitubercular drugs, which of the following drugs is classified under Group II?

Streptomycin. The classification of antitubercular drugs has been updated by the WHO to prioritize oral regimens and optimize the treatment of Drug-Resistant TB (DR-TB). **Explanation of the Correct Answer:** **Streptomycin** is classified under **Group II** (Second-line Injectable Agents). Historically, this group included Kanamycin, Capreomycin, and Amikacin. However, in the most recent WHO guidelines, Streptomycin remains the representative injectable for this category, though its use is declining in favor of all-oral regimens. **Analysis of Incorrect Options:** * **Ethambutol (Option A):** This is a **Group I** drug (First-line oral agents). Group I includes the primary "HRZE" regimen (Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol). * **Levofloxacin (Option B):** This belongs to **Group A** (Fluoroquinolones) in the newer MDR-TB classification. Fluoroquinolones (Levofloxacin, Moxifloxacin) are now considered the most important components of MDR-TB treatment. * **Imipenem (Option D):** This is classified under **Group III** (or Group C in newer nomenclature), which consists of "Add-on agents" or "Other second-line agents" like Linezolid, Clofazimine, and Carbapenems. **NEET-PG High-Yield Pearls:** * **New WHO MDR-TB Classification:** * **Group A:** Fluoroquinolones (Levofloxacin, Moxifloxacin). * **Group B:** Second-line oral agents (Clofazimine, Cycloserine). * **Group C:** Add-on agents (Ethionamide, Linezolid, Bedaquiline, Delamanid). * **Bedaquiline:** Inhibits mycobacterial ATP synthase; it is a breakthrough drug for MDR-TB. * **Streptomycin Side Effect:** Ototoxicity (vestibular damage) and nephrotoxicity; it is contraindicated in pregnancy.

Q: Which of the following antibiotics can cause diabetes insipidus?

Demeclocycline. **Explanation:** **Demeclocycline** is a tetracycline derivative that acts as a specific antagonist to **Antidiuretic Hormone (ADH)** at the level of the renal collecting ducts. It inhibits the activation of adenylyl cyclase and the subsequent action of cAMP, rendering the kidneys unresponsive to ADH. This induced state of **nephrogenic diabetes insipidus** is actually utilized therapeutically to treat **SIADH** (Syndrome of Inappropriate ADH secretion)

Q: What is the drug of choice in a patient with severe complicated falciparum malaria?

Artesunate. **Explanation:** **Artesunate** is the current **Drug of Choice (DOC)** for severe or complicated *Plasmodium falciparum* malaria, as recommended by both the WHO and National Guidelines. 1. **Why Artesunate is correct:** Intravenous (IV) Artesunate is a water-soluble artemisinin derivative that acts rapidly against all erythrocytic stages of the parasite (including young rings). It clears parasitemia faster than quinine and significantly reduces mortality rates in both adults (SEAQUAMAT trial) and children (AQUAMAT trial). It also has a superior safety profile with a lower risk of hypoglycemia. 2. **Why other options are incorrect:** * **Chloroquine:** While it was once the mainstay, widespread resistance in *P. falciparum* makes it ineffective for severe cases. It is now primarily used for *P. vivax* (where sensitive). * **Quinine:** Previously the DOC, it is now considered a second-line alternative. It requires slow IV infusion, carries a high risk of **cinchonism**, and frequently causes refractory hypoglycemia due to hyperinsulinemia. * **Artemether:** This is a lipid-soluble derivative usually administered intramuscularly. Its absorption is erratic compared to the rapid bioavailability of IV Artesunate, making it less ideal for emergency stabilization. **High-Yield Clinical Pearls for NEET-PG:** * **Dosing Schedule:** IV Artesunate is given at 0, 12, and 24 hours, then once daily. * **Transition:** Once the patient can tolerate oral medication, a full 3-day course of **ACT (Artemisinin-based Combination Therapy)** must be completed. * **Side Effect:** Watch for **Post-Artesunate Delayed Hemolysis (PADH)**, which can occur 1–3 weeks after treatment. * **Pregnancy:** IV Artesunate is safe and recommended for severe malaria in **all trimesters** of pregnancy.

Q: Beta-lactam ring is present in all of the following except?

Vancomycin. **Explanation:** The core concept tested here is the structural classification of cell wall synthesis inhibitors. **Beta-lactam antibiotics** are defined by the presence of a four-membered beta-lactam ring, which is essential for their antibacterial activity as it mimics the D-Ala-D-Ala substrate of penicillin-binding proteins (PBPs). **Why Vancomycin is the correct answer:** Vancomycin is a **Glycopeptide** antibiotic, not a beta-lactam. While it also inhibits cell wall synthesis, its mechanism is distinct: it binds directly to the **D-Ala-D-Ala terminus** of the nascent peptidoglycan pentapeptide, sterically hindering polymerization (transglycosylation). It lacks the beta-lactam ring structure entirely. **Analysis of Incorrect Options:** * **Sulbactam:** This is a **Beta-lactamase inhibitor**. Although it has weak intrinsic antibacterial activity, it possesses a beta-lactam ring that allows it to act as a "suicide inhibitor" by binding irreversibly to beta-lactamase enzymes. * **Imipenem:** This belongs to the **Carbapenem** class. Carbapenems are characterized by a beta-lactam ring fused to a five-membered ring system with a carbon at position 1. * **Cephalexin:** This is a **First-generation Cephalosporin**. All cephalosporins contain a beta-lactam ring fused to a six-membered dihydrothiazine ring. **High-Yield Clinical Pearls for NEET-PG:** 1. **Beta-lactam families:** Penicillins, Cephalosporins, Monobactams (e.g., Aztreonam), Carbapenems, and Beta-lactamase inhibitors (Clavulanic acid, Sulbactam, Tazobactam). 2. **Vancomycin "Red Man Syndrome":** An infusion-related reaction caused by direct histamine release (not a true IgE-mediated allergy). 3. **Mechanism of Resistance:** The most common resistance to Vancomycin (VRSA/VRE) involves the alteration of the binding site from **D-Ala-D-Ala to D-Ala-D-Lac**.

Question 1

What is the mechanism of action of aminoglycosides?

Accepted Answer

Inhibition of protein synthesis

Answer

Damage to cell membrane

Answer

Coagulation of proteins

Answer

Inhibition of cell wall synthesis

Question 2

All of the following are antifungal drugs that inhibit ergosterol biosynthesis EXCEPT?

Accepted Answer

Amphotericin B

Answer

Ketoconazole

Answer

Fluconazole

Answer

None of these

Question 3

During treatment with rifampicin, some patients experience mild elevation in bilirubin with normal transaminases. What is the cause of this phenomenon?

Accepted Answer

Hepatic adaptation

Answer

Hemolysis

Answer

Transient cholestasis with bile duct injury

Answer

Microsomal enzyme induction

Question 4

Which of the following is the drug of choice for Campylobacter jejuni infection?

Accepted Answer

Erythromycin

Answer

Azithromycin

Answer

Metronidazole

Answer

Ampicillin

Question 5

What is the standard oral dose of oseltamivir for treatment?

Accepted Answer

75 mg twice daily for 5 days orally

Answer

75 mg twice daily for 5 days intravenously

Answer

200 mg twice daily for 5 days orally

Answer

200 mg twice daily for 5 days intravenously

Question 6

What is the most important side effect of Amphotericin B?

Accepted Answer

Nephrotoxicity

Answer

Fever and chills

Answer

Hyperkalemia

Answer

Anemia

Question 7

According to the recent classification of antitubercular drugs, which of the following drugs is classified under Group II?

Accepted Answer

Streptomycin

Answer

Ethambutol

Answer

Levofloxacin

Answer

Imipenem

Question 8

Which of the following antibiotics can cause diabetes insipidus?

Accepted Answer

Demeclocycline

Answer

Chloramphenicol

Answer

Minocycline

Answer

Linezolid

Question 9

What is the drug of choice in a patient with severe complicated falciparum malaria?

Accepted Answer

Artesunate

Answer

Chloroquine

Answer

Quinine

Answer

Artemether

Question 10

Beta-lactam ring is present in all of the following except?

Accepted Answer

Vancomycin

Answer

Sulbactam

Answer

Imipenem

Answer

Cephalexin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?